Program areas at Gladstone Institutes
The institute of neurological disease maintains a strong focus on neurodegenerative and neuroinflammatory diseases, including alzheimer's disease and other dementias, parkinson's disease, amyotrophic lateral sclerosis (als), and multiple sclerosis. The investigators are searching for common threads that will allow them to identify therapeutic interventions that might benefit multiple conditions. They are using unconventional approaches to identify such multi-faceted solutions, while also leveraging capabilities in regenerative and personalized medicine.
The institute of cardiovascular disease leverages important genetic, developmental, chemical, biological systems, computational, and engineering approaches to study heart disease and stem cell biology.
The institute of virology has made significant contributions to fight hiv/aids, sars-cov-2, hepatitis c, zika, and cytomegalovirus infections leading to global and groundbreaking efforts in hiv prevention and cure. Its state of The art bsl3 laboratories have allowed Gladstone to do groundbreaking work in understanding The covid-19 virus and other virus driven diseases. By focusing on prevention, diagnosis, and therapeutics, The institute aims to develop proactive strategies to tackle current and future pandemics.
The Gladstone institute of data science and biotechnology invests in talent to create new ways to analyze and integrate datasets, including machine learning approaches that leverage The rapid advances in artificial intelligence. It will be The home for development of new technologies that can accelerate discovery in all areas of investigation at Gladstone. Gladstone - ucsf institute of genomic immunology blends The latest genomics and genome engineering technologies with immunology research to engineer The human immune system for therapeutic benefit.